Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Rhythm Pharmaceuticals (RYTM) Shares Outstanding: 2016-2025

Historic Shares Outstanding for Rhythm Pharmaceuticals (RYTM) over the last 8 years, with Sep 2025 value amounting to $66.7 million.

  • Rhythm Pharmaceuticals' Shares Outstanding rose 8.54% to $66.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.7 million, marking a year-over-year increase of 8.54%. This contributed to the annual value of $62.4 million for FY2024, which is 4.99% up from last year.
  • Per Rhythm Pharmaceuticals' latest filing, its Shares Outstanding stood at $66.7 million for Q3 2025, which was up 4.34% from $63.9 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Shares Outstanding high stood at $66.7 million for Q3 2025, and its period low was $50.2 million during Q1 2021.
  • In the last 3 years, Rhythm Pharmaceuticals' Shares Outstanding had a median value of $61.1 million in 2024 and averaged $61.1 million.
  • Data for Rhythm Pharmaceuticals' Shares Outstanding shows a peak YoY increased of 13.87% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Rhythm Pharmaceuticals' Shares Outstanding stood at $50.3 million in 2021, then increased by 12.59% to $56.6 million in 2022, then climbed by 4.97% to $59.4 million in 2023, then rose by 4.99% to $62.4 million in 2024, then rose by 8.54% to $66.7 million in 2025.
  • Its Shares Outstanding stands at $66.7 million for Q3 2025, versus $63.9 million for Q2 2025 and $63.5 million for Q1 2025.